The role of cytochromes P-450 in cyclosporine metabolism

Journal of the American Academy of Dermatology

Volumn 23, Issue 6, 1990, Pages 1301-1311

  Watkins, Paul B ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYTOCHROME P450;

CONFERENCE PAPER; DRUG ABSORPTION; DRUG INTERACTION; DRUG METABOLISM; HUMAN; INTESTINE; LIVER; PRIORITY JOURNAL;

CYCLOSPORINS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; HUMAN; INTESTINES; LIVER;

EID: 0025647855     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/0190-9622(90)70358-O     Document Type: Article

References (66)

1. Hypothesis: cyclosporin, low-density lipoprotein, and cholesterol
2. Cyclosporin: pharmacokinetics and metabolism
3. The P450 superfarnily: updated listing of all genes and recommended nomenclature for the chromosomal loci
4. Characterization of human microsomal cytochrome P-450 enzymes
5. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines
6. Methylcholanthrene but not phenobarbital enhances caffeine and theophylline metabolism in cultured adult human hepatocytes
7. Genetically determined polymorphisms in drug oxidation
8. Metabolism of cyclosporin A: Purification and identification of the rifampicin-inducible human liver cytochrome P-460 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily
9. Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-inetabolizing enzyme explains interactions of cyclosporine with other drugs
10. Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver: cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCNl and hPCN3 for the metabolism of steroid hormones and cyclosporine
11. Identification of an inducible form of cytochrome P-450 in human liver
12. Demonstration in multiple species of inducible hepatic cytochromes P-450 and their mRNAs related to the glucocorticoid-inducible cytochrome P-450 of the rat
13. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism
14. The erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450
15. Cyclosporine drug interactions: a review
16. Rapid metabolism of cyclosporin and prednisone in kidney transplant patient receiving tuberculostatic treatment [Letter]
17. Update on rifampin drug interactions
18. The increase in urinary excretion of 6/β-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction
19. Cyclosporin A drug interactions: screening for inducers and inhibitors of cytochrome P450 (cyclosporin A oxidase) in primary cultures of human hepatocytes
20. The effect of agents that alter drug metabolizing enzyme activity on the pharmacokinetics of cyclosporine [Letter]
21. Cyclosporin-erythromycin interaction in renal transplant patients
22. The effects of erythromycin in patients treated with cyclosporine
23. Cyclosporin-erythromycin interaction in normal subjects
24. Erythromycin-rnduced drug interactions: An illustrative case and review of the literature
25. Erythromycin-cyclosporin interaction
26. Possible interaction between cyclosporine and erythromycin [Letter]
27. Effect of erythromycin on cyclosporine levels
28. Erythromycin and cyclosporine interactions [Letter]
29. Interaction between erythromycin and cyclosporine in a kidney and pancreas allograft recipient
30. Concomitant administration of cyclosporin and ketoconazole in renal transplant recipients
31. Cyclosporine-ketoconazole: a potentially dangerous drug interaction [Letter]
32. Use of cyclosporine and ketoconazole without nephrotoxicity in two heart transplant recipients
33. Influence of diltiazem on cyclosporin clearance [Letter]
34. Cyclosporin-diltiazem interaction [Letter]
35. Cyclosporin-diltiazem interaction: comparison of cyclosporin levels measured with two monoclonal antibodies
36. Effect of the calcium channel blocker diltiazem on cyclosporine A blood levels and dose requirements
37. Cyclosporin-verapamil interaction [Letter]
38. Evaluation of cyclosporin-verapamil interaction, with observations on parent cyclosporin and metabolites [Letter]
39. Increased cyclosporine blood concentrations due to verapamil administration
40. Confirmation of the interaction between cyclosporine and the calcium channel blocker nicardipine in renal transplant patients
41. Influence of nicardipine on renal function and plasma cyclosporin in renal transplant patients
42. Nicardipine increases cyclosporin blood levels [Letter]
43. Cyclosporin-nicardipine interaction in the kidney-transplant patient
44. Interaction between cyclosporin and rifampicin [Abstract]
45. Interaction between cyclosporin A and phenobarbitone
46. Cyclosporin-phenytoin interaction: re-evaluation using metabolite data
47. Cyclosporine-phenytoin interaction
48. Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites
49. Interaction between phenytoin and cyclosporine following organ transplantation
50. Drug interaction between cyclosporin and phenytoin in allogenic bone marrow transplantation
51. Cyclosporine and tegretol—another drug interaction [Letter]
52. Cyclosporine-cimetidine interaction
53. Macrolide antibiotics inhibit the degradation of the glucocorticoid-re-sponsive cytochrome P-450p in rat hepatocytes in vivo and in primary monolayer culture
54. Ranitidine, Cimetidine, and the cyclosporine-treated recipient
55. Inhibition of cyclosporin metabolism by other drugs in vitro
56. The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver
57. Characterization of ethanol-inducible human liver N-nitrosodimeth-ylamine demethylase
58. Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450IIIA
59. Pharmacokinetic drug interactions with macrolide antibiotics
60. Inhibition of prednisolone metabolism by cyclosporine in kidney-transplanted patients
61. Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man
62. Heterogeneity of P450IIIA expression in human gut epithelia [Abstract]
63. Cyclosporin metabolism by cytochrome P-450IIIA in rat enterocytes: Another determinant of oral bioavailability
64. Cyclosporin A drug interactions: screening for inducers and inhibitors of cytochrome P450 (cyclosporin A oxidase) in primary cultures of human hepatocytes
65. Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCNl and hPCN3 for the metabolism of steroid hormones and cyclosporine